Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine

BURLINGTON, N.C. (January 29, 2025) – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine's 2025 list of the World’s Most Admired Companies,™ a recognition of the most respected and reputable companies globally.

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. , Jan. 10, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14 , at 3:45 p.m.

Labcorp and Inspira Health Announce Strategic Agreement For Lab Operations

BURLINGTON, N.C., (Jan. 9, 2025) — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into a strategic collaboration with Inspira Health to manage the daily operations of the health system’s hospital laboratories located in Vineland, Elmer and Mullica Hill, New Jersey

LABCORP DECLARES QUARTERLY DIVIDEND

BURLINGTON, N.C. , Jan. 8, 2025 /PRNewswire/ --  Labcorp Holdings Inc.  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

BURLINGTON, N.C. , Jan. 8, 2025 /PRNewswire/ --  Labcorp Holdings Inc.  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025 .

Labcorp And Graves Gilbert Clinic Announce Strategic Agreement for Lab Operations

BURLINGTON, N.C., (Dec. 19, 2024) — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into a comprehensive strategic agreement with Graves Gilbert Clinic to manage the lab operations of its main full-service laboratory in Bowling Green, Kentucky, and its location in Glasgow, Kentucky.

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows BURLINGTON, N.C. , Dec. 17, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today

Labcorp To Acquire Select Assets of MAWD Pathology Group

BURLINGTON, N.C., (Dec. 16, 2024) — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into an agreement with MAWD Pathology Group in Lenexa, Kansas, to acquire select assets of the independent laboratory’s clinical and women’s health testing businesses.

Labcorp Finalizes Acquisition of Select Outreach Services From Ballad Health

JOHNSON CITY, Tenn. and BURLINGTON, NC, (Dec. 11, 2024) - Labcorp, a global leader of innovative and comprehensive laboratory services, announces it has finalized its acquisition of select outreach laboratory services from Ballad Health. 

Labcorp Acquires Select Assets of Lab Works

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has finalized its acquisition of select assets and molecular testing location of Lab Works, an accredited independent clinical laboratory located in Birmingham, Alabama.